Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors. [electronic resource]
Producer: 20211101Description: 4064-4071 p. digitalISSN:- 1557-3265
- Aged
- Biomarkers, Tumor -- blood
- Brain Neoplasms -- blood
- Circulating Tumor DNA -- blood
- Female
- Follow-Up Studies
- GTP Phosphohydrolases -- blood
- Humans
- Immune Checkpoint Inhibitors -- therapeutic use
- Kaplan-Meier Estimate
- Longitudinal Studies
- Male
- Melanoma -- blood
- Membrane Proteins -- blood
- Middle Aged
- Mutation
- Prognosis
- Proto-Oncogene Proteins B-raf -- blood
- Proto-Oncogene Proteins c-kit -- genetics
- Risk Assessment -- methods
- Skin Neoplasms -- blood
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.